Show simple item record

dc.contributor.authorCampaign for Access to Essential Medicines
dc.date.accessioned2008-09-05T08:58:26Z
dc.date.available2008-09-05T08:58:26Z
dc.date.issued2008-06
dc.date.submitted2008-08-28
dc.identifier.citationRev Soc Bras Med Trop 2008;4(3):315-9en
dc.identifier.issn0037-8682
dc.identifier.pmid18719818
dc.identifier.urihttp://hdl.handle.net/10144/37313
dc.description.abstractTrypanosoma cruzi infection is often not detected early on or actively diagnosed, partly because most infected individuals are either asymptomatic or oligosymptomatic. Moreover, in most places, neither blood banks nor healthcare units offer diagnostic confirmation or treatment access. By the time patients present clinical manifestations of advanced chronic Chagas disease, specific treatment with current drugs usually has limited effectiveness. Better-quality serological assays are urgently needed, especially rapid diagnostic tests for diagnosis patients in both acute and chronic phases, as well as for confirming that a parasitological cure has been achieved. Some new antigen combinations look promising and it is important to assess which ones are potentially the best, together with their requirements in terms of investigation and development. In August 2007, a group of specialized researchers and healthcare professionals met to discuss the state of Chagas infection diagnosis and to build a consensus for a plan of action to develop efficient, affordable, accessible and easy-to-use diagnostic tests for Chagas disease. This technical report presents the conclusions from that meeting.
dc.languageENG
dc.language.isoenen
dc.relation.urlhttp://dx.doi.org/10.1590/S0037-86822008000300020en
dc.rightsArchived with thanks to Revista da Sociedade Brasileira de Medicina Tropicalen
dc.subject.meshChagas Diseaseen
dc.subject.meshTrypanosoma cruzien
dc.subject.meshAmerican Trypanosomiasisen
dc.subject.meshDiagnostic Testsen
dc.subject.meshSerologyen
dc.titleInternational meeting: New diagnostic tests are urgently needed to treat patients with Chagas disease.en
dc.typeArticleen
dc.contributor.departmentCampaign for Access to Essential Medicines, Médecins Sans Frontièresen
dc.identifier.journalRevista da Sociedade Brasileira de Medicina Tropicalen
refterms.dateFOA2019-03-04T11:55:17Z
html.description.abstractTrypanosoma cruzi infection is often not detected early on or actively diagnosed, partly because most infected individuals are either asymptomatic or oligosymptomatic. Moreover, in most places, neither blood banks nor healthcare units offer diagnostic confirmation or treatment access. By the time patients present clinical manifestations of advanced chronic Chagas disease, specific treatment with current drugs usually has limited effectiveness. Better-quality serological assays are urgently needed, especially rapid diagnostic tests for diagnosis patients in both acute and chronic phases, as well as for confirming that a parasitological cure has been achieved. Some new antigen combinations look promising and it is important to assess which ones are potentially the best, together with their requirements in terms of investigation and development. In August 2007, a group of specialized researchers and healthcare professionals met to discuss the state of Chagas infection diagnosis and to build a consensus for a plan of action to develop efficient, affordable, accessible and easy-to-use diagnostic tests for Chagas disease. This technical report presents the conclusions from that meeting.


Files in this item

Thumbnail
Name:
Chagas-CAME-RioAug2007_RevSocB ...
Size:
113.2Kb
Format:
PDF
Description:
Main article

This item appears in the following Collection(s)

Show simple item record